# Respiratory System & Pulmonology

## Respiratory Tract Embryology Stages

|Mnemonic|Stage|
|-|-|
|Empty|Embryonic|
|Pockets|Pseudoglandular|
|Can|Canalicular|
|Store|Saccular|
|Air|Alveolar|

## Lung Volumes and Measurements

|Indices|Methods|
|-|-|
|IRV & TV & ERV|Spirometry|
|RV|Helium dilution method & Plethysmography|

![](../Figures/Lung%20Volumes.png)

## Perfusion and Diffusion Limited Pulmonary Circulation

![](../Figures/Perfusion%20and%20Diffusion%20Limited%20Pulmonary%20Circulation.png)

## Ventilation/Perfusion (V/Q) Ratio

|Ratio|Conditions|
|-|-|
|0|Shunt|
|Low|Lung base|
|High|Lung apex|
|∞|Dead space|

### Shunt

- Anatomic shunt
	- Intracardiac shunt
	- Pulmonary arteriovenous malformation (AVM)
	- Hepatopulmonary syndrome
- Physiologic shunt
	- Atelectasis
	- Pneumonia
	- Acute respiratory distress syndrome (ARDS)
	- Obstructive lung diseases

### Dead Space

- Pulmonary embolism
- Pulmonary vascular diseases
- Obstructive lung diseases
- Interstitial lung diseases

## Etiology of Kussmaul Breathing {KUSSMAUL}

- Ketoacidosis
- Uremia
- Sepsis
- Salicylate
- Methanol
- Aldehyde
- Uricemia
- Lactic acidosis

## Light Criteria for Pleural Fluid (PF)

|PF|PF ÷ Serum Protein|PF ÷ Serum LDH|PF LDH|
|-|-|-|-|
|Transudate|< 0.5|< 0.6|< 2/3 Serum LDH upper limit|
|Exudate|> 0.5|> 0.6|> 2/3 Serum LDH upper limit|

## Classification of Asthma Severity

|Asthma|Attacks|Awakenings|SABA Uses|FEV<sub>1</sub>|FEV<sub>1</sub>/FVC|
|-|-|-|-|-|-|
|Intermittent|< 2 days/week|≤ 2/month|≤ 2 days/week|> 80%|Normal|
|Mild persistent|2 ~ 7 days/week|3 ~ 4/month|2 ~ 7 days/week|> 80%|Normal|
|Moderate persistent|Daily|> 1/week|Daily|60 ~ 80%|↓ < 0.05|
|Severe persistent|Throughout|Daily|Throughout|< 60%|↓ > 0.05|

## GOLD Staging of Chronic Obstructive Pulmonary Disease (COPD)

|Stage|Severity|FEV<sub>1</sub>|
|-|-|-|
|1|Mild|> 80%|
|2|Moderate|50 ~ 80%|
|3|Severe|30 ~ 50%|
|4|Very severe|< 30%|

## Treatment of Asthma

![](../Figures/Treatment%20of%20Asthma.gif)

## Mechanisms of Action of Medications for Asthma

|Mechanism|Medication|Indications|
|-|-|-|
|β<sub>2</sub> agonists|Albuterol|Asthma :: acute|
||Salmeterol & Formoterol|Asthma :: chronic|
|M antagonists|Ipratropium & Tiotropium|Asthma|
|NF-κB inhibitors|Steroids|Asthma|
|LOX inhibitors|Zileuton|Asthma|
|LTD<sub>4</sub> antagonists|Montelukast|Asthma|
||Zafirlukast|Asthma|
|Mast cell inhibitors|Cromolyn|Asthma|
||Nedocromil|Asthma|
|IgE inhibitors|Omalizumab|Asthma|

## Pathogens of Bronchiolitis

- Adenovirus
- RSV
- Rhinovirus
- Coronavirus
- Parainfluenza virus
- Influenza virus

## Pathogens of Pneumonia

- Streptococcus pneumonia
- Haemophilus influenzae
- Moraxella catarrhalis
- Klebsiella pneumoniae
- Pseudomonas aeruginosa
- Legionella
- Mycoplasma
- Chlamydia
- RSV

## Empirical Antibiotics for Pneumonia

|Patient|Antibiotics|
|-|-|
|CAP & Uncomplicated|Macrolides<br>Doxycycline|
|CAP & Complicated|Amoxicillin & (Macrolides / Doxycycline)<br>Fluoroquinolones|
|CAP & Inpatient|Anti-pseudomonal β-lactams & (Macrolides / Doxycycline)<br>Fluoroquinolones|
|CAP & ICU|Anti-pseudomonal β-lactams & (Macrolides / Doxycycline / Fluoroquinolones)|
|HAP|Anti-pseudomonal β-lactams & Fluoroquinolones|

### Complicated Patients

- Age > 65 y/o
- Antibiotics within 3 months
- Commorbid
